NCT06565390

Brief Summary

This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
700

participants targeted

Target at P75+ for not_applicable

Timeline
57mo left

Started Sep 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Sep 2025Dec 2030

First Submitted

Initial submission to the registry

July 29, 2024

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 22, 2024

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 11, 2025

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2027

Expected
3.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

2.1 years

First QC Date

July 29, 2024

Last Update Submit

September 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Emergency room visits and high-acuity rehospitalizations.

    Number of emergency room visits and high-acuity rehospitalizations.

    6 months

Secondary Outcomes (11)

  • Number of participants with serious outcome events

    6 months

  • High-acuity rehospitalizations

    6 months

  • All-cause mortality.

    6 months

  • Other rehospitalizations

    6 months

  • Emergency room visits

    6 months

  • +6 more secondary outcomes

Study Arms (2)

Babies in the Owlet monitor group

EXPERIMENTAL

The Owlet group will be given an Owlet OSS 3.0 monitor to wear when sleeping. The Owlet alarms if the baby has a very low heart rate or very low oxygen levels. In addition, caregivers in the Owlet group with a smart phone and Wi-Fi access will be able to use an application to monitor the baby's vital signs and sleep state. Will complete a survey or questionnaire every month until 6 months after discharge.

Device: Babies in the Owlet monitor group

Babies in the Usual Care Group

NO INTERVENTION

The usual care group will not be given an Owlet vital sign monitor. Will complete a survey or questionnaire every month until 6 months after discharge.

Interventions

The Owlet group will be given an Owlet OSS 3.0 monitor to wear when sleeping. The Owlet alarms if the baby has a very low heart rate or very low oxygen levels. In addition, caregivers in the Owlet group with a smart phone and Wi-Fi access will be able to use an application to monitor the baby's vital signs and sleep state.

Babies in the Owlet monitor group

Eligibility Criteria

Age22 Weeks - 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants being discharged from the NICU
  • Off all respiratory support (oxygen, CPAP, ventilator) before discharge home
  • Gestational age ≥ 22 0/7 weeks' gestation at birth
  • Parents/legal guardians have provided consent for enrollment

You may not qualify if:

  • a major malformation, a neuromuscular condition that affects respiration or causes apnea, complex congenital heart disease and hemodynamically significant shunts, or terminal illness or decision to withhold or limit support.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35249, United States

RECRUITING

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Colm P Travers, M.D.

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kimberly Armstead, BS

CONTACT

Rachel Benz, MSN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study will have two groups. One group will use the Owlet OSS 3.0 pulse oximeter and the other group will not.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 29, 2024

First Posted

August 22, 2024

Study Start

September 11, 2025

Primary Completion (Estimated)

October 31, 2027

Study Completion (Estimated)

December 31, 2030

Last Updated

September 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

We will only share aggregate data with the study sponsor and with data analyst.

Locations